Abstract:Objectives Stem cell therapy is a potential option for treating myocardial infarction. However, the effect is not as well as we expected. As a matter of fact, cell therapy is faced a lot of challenges, such as poor survival of the transplanted cells in the infracted region, low number of cells migrated into myocardial lesions, and so on. So the aim of this study is to explore a new strategy that angiotensin receptor type 2 stimulation can improve the engraftment of bone marrow mononuclear cells in the infracted myocardium and recover heart function. Methods Mononuclear cells (MNCs), isolated from SD rat bone marrow, were treated with several reagents which can change the activity of AT2R of MNCs. The experiment group designation for in vitro study were: MNCs (control), MNCs+AngII, MNCs+CGP42112A, MNCs+AngII+ARB, MNCs+AngII+PD123319 and MNCs+CGP+ARB. The ability of migration and cardioprotection were examined by tran-swell and co-culturing with neonatal cardiomyocytes. The experiment group designation for in vivo study were: DMEM, MNCs, MNCs+CGP42112A and MNCs+AngII+ARB. Cells from different groups were intramyocardially injected into the peri-infarct region. Inflammatory cytokine expression, death of cardiomyocyte, anti-apoptotic protein expression were assessed 3 days after transplantation. Meanwhile we transplant above-mentioned female rats'cells into male rats via tail vein, and evaluate the number of engrafted cells 1 day after transplantation by real-time PCR. Infarct size, angiogenesis and heart function were measured 1 month after transplantation. Results Bone marrow mononuclear cells, when their AT2R were stimulated, can prevent neonatal cardiomyocytes from apoptosis in vitro. Also more cells migrated into low chamber in same situation. Transplantation of AT2R-activated bone marrow cells intramyocardially after myocardial infarction resulted in decrease in inflammatory cytokines (IL-1, IL-6, MCP-1) expression, death rate of cardiomyocytes in peri-infarcted region, as well as increase in anti-apoptotic protein expression (Bcl2). Also more bone marrow mononuclear cells were found in myocardial lesions 1 d after transplantation via tail vein. No matter which transplanted routes we choose, transplantation of AT2R-activated bone marrow cells can improve heart function significantly. Conclusions Angiotensin receptor type 2 stimulation can increase the migration of bone-marrow mononuclear cells into the infracted myocardium and prevent cardiomyocytes from apoptosis, thus activate AT2R of bone marrow stem cells maybe a novel option for enhancing benefits of stem cell therapy.

Effect of Angiotensin II Type 2 Receptor Deletion in Hematopoietic Cells on Brain Ischemia-Reperfusion Injury.

Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Evidence for A Depressor Action of At1 Receptors in the Nucleus of the Solitary Tract (Nts)

Anti‐inflammatory Action of Angiotensin‐(1–7) and the Angiotensin Type 2 Receptor Agonist Compound 21 in Hypothalamic Microglia

Angiotensin II Type 2 Receptor Inhibits M1 Polarization and Apoptosis of Alveolar Macrophage and Protects Against Mechanical Ventilation-Induced Lung Injury

Angiotensin Receptor Type 2 Stimulation Increases the Migration of Bone-Marrow Mononuclear Cells into the Infarcted Myocardium and Improves Heart Function

Identification of noncytotoxic and IL-10-producing CD8+AT2R + T cell population in response to ischemic heart injury

Lack of the Brain-Specific Isoform of Apoptosis-Inducing Factor Aggravates Cerebral Damage in a Model of Neonatal Hypoxia–ischemia

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition

Angiotensin II Type 1a Receptor is Involved in Cell Infiltration, Cytokine Production, and Neovascularization in Infarcted Myocardium

Effect of ACE2 deletion on vasoconstriction reactivity of aortic segments in mice with tourniquet shock

Inactivation of endothelial adenosine A(2A) receptors protects mice from cerebral ischaemia-induced brain injury

Effects of chronic peripheral pretreatment with an angiotensin II type-1 receptor blocker on apoptosis-related molecules in rats with cerebral ischemia/reperfusion injury

Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury

The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke

Delayed administration of an angiotensin II type 2 receptor agonist promotes functional recovery of the brain and heart after traumatic brain injury

Restoration of Brain Angiotensin-Converting Enzyme 2 Alleviates Neurological Deficits after Severe Traumatic Brain Injury via Mitigation of Pyroptosis and Apoptosis

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Adenosine A2A Receptor Deficiency Exacerbates White Matter Lesions and Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion in Mice